You Searched


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Pain relief Durnox SP 8mg/325mg/15mg Tablet relieves pain, reduce swelling and ease inflammation in conditions like rheumatoid arthritis and osteoarthritis. It gives relief from muscle and back pain, or pain in the ear and throat. Durnox SP 8mg/325mg/15mg Tablet is also used for the management of pain in patients after dental surgery. It works by reducing substances in the body that cause pain and swelling. By reducing pain, it improves the quality of your life. Durnox SP 8mg/325mg/15mg Tablet also reduces fever associated with the above painful conditions. This medicine also contains an active ingredient called Serratiopeptidase, which is an enzyme that promotes the overall healing process and speeds up recovery.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Durnox SP 8mg/325mg/15mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
Durnox SP 8mg/325mg/15mg Tablet is a combination of three medicines: Lornoxicam, Paracetamol and Serratiopeptidase which relieve pain. Lornoxicam is a non-steroidal antiinflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation, and promotes healing.
Unsafe: Avoid consuming alcohol with Durnox SP 8mg/325mg/15mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Durnox SP 8mg/325mg/15mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Durnox SP 8mg/325mg/15mg Tablet during breastfeeding is not available. Doctor consultation is advised.
Not Safe: Durnox SP 8mg/325mg/15mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Durnox SP 8mg/325mg/15mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Durnox SP 8mg/325mg/15mg Tablet may not be needed in these patients. Doctor consultation is advised.
Caution Advised: Durnox SP 8mg/325mg/15mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Durnox SP 8mg/325mg/15mg Tablet may be needed. Doctor consultation is advised. However, the use of Durnox SP 8mg/325mg/15mg Tablet is not recommended in patients with severe liver disease and active liver disease.
If a dose of Durnox SP 8mg/325mg/15mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Plot 197, Industrial Area Phase 1, Panchkula, Haryana 134112
PubChem. Serratiopeptidase (02 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.